Search results for "GLP-1 obesity treatment"

"My Cancer Treatment Is Over, but I Keep Gaining Weight": 6 in 10 Post-Surgery Patients Struggle With Weight Management

For patients returning to daily life following cancer treatment, managing body weight presents a secondary, formidable challenge.
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul

Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul

What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the next generation of...
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why

To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why

As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound

Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound

Popular anti-obesity injections like Wegovy and Mounjaro reduce appetite and prolong feelings of fullness.
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%

Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.